Orbimed Advisors LLC Trillium Therapeutics Inc. Call Options Transaction History

Orbimed Advisors LLC

  • $2.8 Billion
  • Q2 2025

Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021
BUY
N/A
1,700 New
1,700 $18,000

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email